ONTRAK INC.PRF.SER.A DL25
Ontrak, Inc. operates as a value-based behavioral healthcare company in the United States. The company's program predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care and treatment they need. Its technology-enabled solutions are designed to provide healthcar… Read more
ONTRAK INC.PRF.SER.A DL25 (HY1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ONTRAK INC.PRF.SER.A DL25 (HY1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ONTRAK INC.PRF.SER.A DL25 - Net Assets Trend (None–None)
This chart illustrates how ONTRAK INC.PRF.SER.A DL25's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ONTRAK INC.PRF.SER.A DL25 (None–None)
The table below shows the annual net assets of ONTRAK INC.PRF.SER.A DL25 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ONTRAK INC.PRF.SER.A DL25's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ONTRAK INC.PRF.SER.A DL25 Competitors by Market Cap
The table below lists competitors of ONTRAK INC.PRF.SER.A DL25 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PUMA ENERGY ZAMBIA PLC
LUSE:PUMA
|
$917.95 |
|
Leather Up Ltd
KAR:LEUL
|
$918.12 |
|
MRS OIL NIGERIA PLC
XNSA:MRS
|
$918.56 |
|
Franklin Credit Management Corporation
PINK:FCRM
|
$918.70 |
|
BAYPORT MANAGEMENT LTD - (USD)
SEM:BAYP
|
$915.27 |
|
Mena Touristic & Real Estate Investment
EGX:MENA
|
$915.26 |
|
TRULY INTL HLDGS (TYU2.SG)
STU:TYU2
|
$914.81 |
|
VJTTY
PINK:VJTTY
|
$913.00 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ONTRAK INC.PRF.SER.A DL25's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ONTRAK INC.PRF.SER.A DL25's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ONTRAK INC.PRF.SER.A DL25 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ONTRAK INC.PRF.SER.A DL25's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ONTRAK INC.PRF.SER.A DL25 (HY1) | €- | N/A | N/A | $915.43 |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |